Selective activator of human ClpP triggers cell cycle arrest to inhibit lung squamous cell carcinoma
Abstract Chemo-activation of mitochondrial ClpP exhibits promising anticancer properties. However, we are currently unaware of any studies using selective and potent ClpP activators in lung squamous cell carcinoma. In this work, we report on such an activator, ZK53, which exhibits therapeutic effect...
| Published in: | Nature Communications |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2023-11-01
|
| Online Access: | https://doi.org/10.1038/s41467-023-42784-4 |
